European Journal of Heart Failure

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Circular RNAs in heart failure
European Journal of Heart Failure - Tập 19 Số 6 - Trang 701-709 - 2017
Yvan Devaux, Esther E. Creemers, Reinier A. Boon, Stanislas Werfel, Thomas Thum, Stefan Engelhardt, Stefanie Dimmeler, Iain Squire
AbstractCardiovascular disease, and particularly heart failure, is still a serious health care issue for which novel treatments and biomarkers are needed. The RNA family comprises different subgroups, among which the small‐sized microRNAs and ...... hiện toàn bộ
Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers
European Journal of Heart Failure - Tập 10 Số 12 - Trang 1186-1191 - 2008
Guıdo Grassı, G. Bolla, Fosca Quartı-Trevano, Francesca Arenare, Gianmaria Brambilla, Giuseppe Mancia
AbstractObjective:To assess the reproducibility of the two markers of adrenergic drive, venous plasma norepinephrine (NE) and efferent postganglionic muscle sympathetic nerve activity (MSNA), in reflecting the sympathetic activation characterizing congestive heart failure (CHF).Methods and...... hiện toàn bộ
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
European Journal of Heart Failure - Tập 21 Số 3 - Trang 272-285 - 2019
Rudolf A. de Boer, Mihai Gheorghiade, Johann Bauersachs, Dirk L. Brutsaert, John G.F. Cleland, Javier Dı́ez, Xiao-Jun Du, Paul Ford, Frank R. Heinzel, Kenneth E. Lipson, Theresa A. McDonagh, Natalia López‐Andrés, Ida G. Lunde, Alexander R. Lyon, Piero Pollesello, Sanjay Prasad, Carlo G. Tocchetti, Manuel Mayr, Joost P. G. Sluijter, Thomas Thum, Carsten Tschöpe, Faı̈ez Zannad, Wolfram‐Hubertus Zimmermann, Frank Ruschitzka, Gerasimos Filippatos, Merry L. Lindsey, Christoph Maack, Stéphane Heymans
AbstractFibrosis is a pivotal player in heart failure development and progression. Measurements of (markers of) fibrosis in tissue and blood may help to diagnose and risk stratify patients with heart failure, and its treatment may be effective in preventing heart failure and its progression. A lack of pathophysiological insights and uniform definitions has hampered...... hiện toàn bộ
Epidemiology and clinical course of heart failure with preserved ejection fraction
European Journal of Heart Failure - Tập 13 Số 1 - Trang 18-28 - 2011
Carolyn S.P. Lam, Erwan Donal, Elisabeth Kraigher‐Krainer, Ramachandran S. Vasan
Heart failure with preserved ejection fraction (HFPEF) is increasingly recognized as a major public health problem worldwide. Significant advances have been made in our understanding of the epidemiology of HFPEF over the past two decades, with the publication of numerous population‐based epidemiological studies, large heart failure registries, and randomized clinical trials. These recent s...... hiện toàn bộ
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
European Journal of Heart Failure - Tập 23 Số 10 - Trang 1610-1632 - 2021
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, Johann Bauersachs, John G.F. Cleland, Andrew J.S. Coats, James L. Januzzi, Alan S. Maisel, Kenneth McDonald, Thomas Mueller, Mark Richards, Petar Seferović, Christian Mueller, Rudolf A. de Boer
AbstractNew biomarkers are being evaluated for their ability to advance the management of patients with heart failure. Despite a large pool of interesting candidate biomarkers, besides natriuretic peptides virtually none have succeeded in being applied into the clinical setting. In this review, we examine the most promising emerging candidates for clinical assessme...... hiện toàn bộ
The strengths and limitations of E/e' in heart failure with preserved ejection fraction
European Journal of Heart Failure - Tập 20 Số 9 - Trang 1312-1314 - 2018
Masaru Obokata, Barry A. Borlaug
Time to end the war on cell therapy
European Journal of Heart Failure - Tập 22 Số 5 - Trang 893-897 - 2020
Roberto Bolli, Arunpreet Kahlon
Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis
European Journal of Heart Failure - Tập 20 Số 4 - Trang 751-757 - 2018
Christine S. Siegismund, Felicitas Escher, Dirk Laßner, Uwe Kühl, Ulrich Gross, Friedrich Fruhwald, Philip Wenzel, Thomas Münzel, Norbert Frey, Reinhold P. Linke, Heinz‐Peter Schultheiß
AimsTo evaluate the influence of endomyocardial biopsy (EMB)‐proven intramyocardial inflammation on mortality in patients with cardiac transthyretin amyloid (ATTR) or amyloid light‐chain (AL) amyloidosis.Methods and resultsWe included 54 consecutive patients (mean age 68.83 ± 9.59 years; 45 me...... hiện toàn bộ
Prognostic electrocardiographic parameters in patients with suspected myocarditis
European Journal of Heart Failure - Tập 13 Số 4 - Trang 398-405 - 2011
Christian Ukena, Felix Mahfoud, Ingrid Kindermann, Reinhard Kandolf, Michael Kindermann, Michael Böhm
Long‐term outcome and its predictors in giant cell myocarditis
European Journal of Heart Failure - Tập 18 Số 12 - Trang 1452-1458 - 2016
Kaj Ekström, Jukka Lehtonen, Riina Kandolin, Anne Räisänen‐Sokolowski, Kaisa Salmenkivi, Markku Kupari
AbstractAimsThere are no studies focusing on prognostic factors in giant cell myocarditis (GCM). We aimed to identify predictors of transplant‐free survival in GCM.Me...... hiện toàn bộ
Tổng số: 89   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 9